Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
Cubillo A, Álvarez-Gallego R, Muñoz M, Pond G, Perea S, Sánchez G, Martin M, Rodríguez-Pascual J, Garralda E, Vega E, de Vicente E, Quijano Y, Muñoz C, Ugidos L, Toledo RA, Hidalgo M. Cubillo A, et al. Among authors: ugidos l. Am J Clin Oncol. 2019 Jan;42(1):56-59. doi: 10.1097/COC.0000000000000474. Am J Clin Oncol. 2019. PMID: 29975196 Clinical Trial.
Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.
Calvo-Plaza I, Ugidos L, Miró C, Quevedo P, Parras M, Márquez C, de la Cruz JJ, Suárez-Gauthier A, Pérez FJ, Herrero M, Marcos M, García-Aranda M, Hidalgo M, Estévez LG. Calvo-Plaza I, et al. Among authors: ugidos l. Clin Transl Oncol. 2013 Mar;15(3):205-10. doi: 10.1007/s12094-012-0899-7. Epub 2012 Aug 8. Clin Transl Oncol. 2013. PMID: 22872518
Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program.
Muñoz C, Riesco Martinez MC, Ugidos L, García-Alfonso P, Alvarez-Gallego R, Peinado P, Toledano C, Mihic-Góngora L, Ortega Anselmi JG, Sanz Garcia E, Vicente E, Quijano Y, Durán HJ, Díaz E, Ferri V, Rubio C, HernandoRequejo O, López González M, Prados S, López U, Allona M, PérezDueñas V, Perez-Escutia MA, Cubillo A. Muñoz C, et al. Among authors: ugidos l. Am J Clin Oncol. 2024 Nov 29. doi: 10.1097/COC.0000000000001157. Online ahead of print. Am J Clin Oncol. 2024. PMID: 39610155
Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report.
Torres Velasco M, Álvarez Gallego R, Peinado P, Muñoz Gregorio C, Ugidos L, García Morillo M, Vicente E, Quijano Y, Prados S, de la Fuente E, Cubillo Gracián A. Torres Velasco M, et al. Among authors: ugidos l. Case Rep Oncol. 2024 Jul 31;17(1):843-851. doi: 10.1159/000539719. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 39144246 Free PMC article.
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Gogate A, Bennett B, Poonja Z, Stewart G, Medina Colmenero A, Szturz P, Carrington C, Castro C, Gemmen E, Lau A, Carral Maseda A, Winquist E, Arrazubi V, Hao D, Cook A, Martinez Galan J, Ugidos L, Fernández Garay D, Gutierrez Abad D, Metcalf R. Gogate A, et al. Among authors: ugidos l. Cancers (Basel). 2023 Jul 9;15(14):3552. doi: 10.3390/cancers15143552. Cancers (Basel). 2023. PMID: 37509217 Free PMC article.